Parkinson's disease and the bones
Markus Gnädinger , H Mellinghoff & Alain Kaelin-Lang
Any newly diagnosed patient with PD should be evaluated for the risk of falling and osteoporosis and routinely be supplemented with vitamin D. In the case of osteoporosis, blood samples for detecting underlying and treatable conditions should be taken and bisphosphonates administered to the patient. It is unclear whether drugs typically used for PD provoke or worsen osteoporosis. Nevertheless, every long-term medication should undergo safety studies to demonstrate lack of negative interference with bone metabolism. Drug admission authorities should demand these data when registering new substances or when renewing old admissions.
|citation||Gnädinger M, mellinghoff h, Kaelin-Lang A. Parkinson's disease and the bones. Swiss Med Wkly 2011; 141:w13154.|
|type||journal paper/review (English)|
|date of publishing||16-02-2011|
|journal title||Swiss Med Wkly (141)|